Zai Lab partners with Amgen for combination cancer therapy trial
Go back to Zai Lab partners with Amgen for combination cancer therapy trial| Amgen Inc (NASDAQ: AMGN) | Delayed: 444.63 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $444.63 | 52 Week High | $176.85 | |||
| Open | $444.63 | 52 Week Low | $133.64 | |||
| Day High | $444.63 | P/E | 66.96 | |||
| Day Low | $444.63 | EPS | $6.64 | |||
| Volume | 1,286 | |||||
| (NASDAQ: ZLAB) | Delayed: 24.34 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $24.34 | 52 Week High | $ | |||
| Open | $24.34 | 52 Week Low | $ | |||
| Day High | $24.34 | P/E | N/A | |||
| Day Low | $24.34 | EPS | $ | |||
| Volume | 17,250 | |||||



